CIK 0000925741 · Non-accelerated filer<br>Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232753988
- Phone
- 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Grant or award President and CEO acquired 110,625 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 60,483 shares (grant or award)
- 4 Grant or award Senior Vice President, Devices acquired 39,521 shares (grant or award)
- 4 Open-market buy Director bought 109,200 shares at an average $0.95 ($103,584)
- 4 Open-market buy President and CEO bought 2,300 shares at an average $0.89 ($2,043)
- 4 Open-market buy President and CEO bought 5,000 shares at $0.85 ($4,250)
- 4 Open-market buy President and CEO bought 1,700 shares at an average $0.92 ($1,570)
- 4 Open-market buy President and CEO bought 5,700 shares at $0.92 ($5,244)
- 4 Open-market buy President and CEO bought 5,100 shares at $1.02 ($5,202)
- 4 Open-market buy President and CEO bought 5,000 shares at $1.11 ($5,550)
- 4 Open-market buy President and CEO bought 1,000 shares at $1.23 ($1,230)
- 4 Open-market buy President and CEO bought 900 shares at an average $1.23 ($1,110)
- 4 Open-market buy President and CEO bought 5,000 shares at $1.13 ($5,650)
- 4 Open-market buy President and CEO bought 900 shares at an average $1.33 ($1,194)
- 4 Open-market buy President and CEO bought 1,100 shares at an average $1.31 ($1,444)
- 4 Grant or award President and CEO acquired 106,588 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 58,276 shares (grant or award)
- 4 Grant or award Senior Vice President, Devices acquired 38,078 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 23 · 442 filings